US-based Martek Biosciences has entered into a multi-year sole source supply agreement with Grupo Ricap, pursuant to which, Martek will supply DHA and ARA in all infant formulas produced by Grupo Ricap in Mexico.
Subscribe to our email newsletter
Grupo Ricap is a third-party manufacturer of infant formula and Martek’s life’sDHA & life’sARA will initially be available in infant formula products produced for a large chain of pharmacies in Mexico and Guatemala.
Ethan Leonard, vice president of pediatric nutrition for Martek, said: “Sole-source agreements like this one further demonstrate that companies across the globe recognize the importance of adding Martek’s trusted sources of DHA and ARA to infant formula and growing up milks for infant health and development. This product launch in Mexico and Guatemala is another step towards Martek’s goal of further expanding into new markets outside of the US.”
Naturally present in human breast milk, DHA (docosahexaenoic acid), and ARA (arachidonic acid) are fatty acids important to infant development and growth. Clinical studies have demonstrated numerous benefits for infants receiving DHA and ARA supplemented formula, including improved mental and visual development.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.